abrdn Life Sciences Investors Total Liabilities

abrdn Life Sciences Investors (HQL) currently reports a total liabilities of $2.4M as of March 2026. That compares with $15M in the prior-year period — down 84.4% year over year. Use the charts on this page to explore abrdn Life Sciences Investors's total liabilities history and peer comparisons.

abrdn Life Sciences Investors's total liabilities decreased from $15M to $2.4M — a 84.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

abrdn Life Sciences Investors reported $2.4M in total liabilities as of March 2026. That compares with $15M in the prior-year period — down 84.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $2.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for abrdn Life Sciences Investors, and consider following HQL for alerts when major investors trade the stock.